{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:46:06Z","timestamp":1793285166075,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004189","name":"Max-Planck-Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2067\/1-0390729940"],"award-info":[{"award-number":["EXC 2067\/1-0390729940"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer\u2019s disease is a specific neurodegenerative disorder, distinct from normal aging, with a growing unmet medical need. It is characterized by the accumulation of amyloid plaques in the brain, primarily consisting of amyloid beta (A\u03b2) fibrils. Therapeutic antibodies can slow down the disease, but are associated with potential severe side effects, motivating the development of small molecules to halt disease progression. This study investigates the interaction between the clinical drug candidate small molecule anle138b and lipidic A\u03b2\u2084\u2080 fibrils of type 1 (L1). L1 fibrils were previously shown to closely resemble fibrils from Alzheimer\u2019s patients. Using high-resolution structural biology techniques, including cryo-electron microscopy (cryo-EM), nuclear magnetic resonance (NMR) spectroscopy enhanced by dynamic nuclear polarization (DNP), and molecular dynamics (MD) simulations, we find that anle138b selectively binds to a cavity within the fibril. This structural insight provides a deeper understanding of a potential drug-binding mechanism at the atomic level and may inform the development of therapies and diagnostic approaches. In addition, anle138b reduces fibril formation in the presence of lipids by approximately 75%. This may suggest a mechanistic connection to its previously reported activity in animal models of Alzheimer\u2019s disease.<\/jats:p>","DOI":"10.1038\/s41467-025-64443-6","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T15:10:38Z","timestamp":1759504238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Anle138b binds predominantly to the central cavity in lipidic A\u03b2\u2084\u2080 fibrils and modulates fibril formation"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8007-5711","authenticated-orcid":false,"given":"Mookyoung","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7877-0262","authenticated-orcid":false,"given":"Benedikt","family":"Frieg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Matthes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Leonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Ryazanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Giller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Nimerovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Stampolaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Overkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2172-5110","authenticated-orcid":false,"given":"Christian","family":"Dienemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Giese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2041-5740","authenticated-orcid":false,"given":"Stefan","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3570-3534","authenticated-orcid":false,"given":"Bert L.","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1803-5431","authenticated-orcid":false,"given":"Gunnar F.","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3216-9065","authenticated-orcid":false,"given":"Loren B.","family":"Andreas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1266-4344","authenticated-orcid":false,"given":"Christian","family":"Griesinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"64443_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297, 353\u2013356 (2002).","journal-title":"Science"},{"key":"64443_CR2","doi-asserted-by":"publisher","first-page":"742408","DOI":"10.3389\/fnagi.2022.742408","volume":"14","author":"MB Abubakar","year":"2022","unstructured":"Abubakar, M. B. et al. Alzheimer\u2019s disease: an update and insights into pathophysiology. Front. Aging Neurosci. 14, 742408 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"64443_CR3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y., Chen, H., Li, R., Sterling, K. & Song, W. Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct. Target. Ther. 8, 248 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"64443_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/msj.20157","volume":"77","author":"DP Perl","year":"2010","unstructured":"Perl, D. P. Neuropathology of Alzheimer\u2019s disease. Mt Sinai J. Med. 77, 32\u201342 (2010).","journal-title":"Mt Sinai J. Med."},{"key":"64443_CR5","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1093\/brain\/awz268","volume":"142","author":"CR Jack Jr","year":"2019","unstructured":"Jack, C. R. Jr et al. The bivariate distribution of amyloid-\u03b2 and tau: relationship with established neurocognitive clinical syndromes. Brain 142, 3230\u20133242 (2019).","journal-title":"Brain"},{"key":"64443_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo, S. et al. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular A\u03b2 and synaptic dysfunction. Neuron 39, 409\u2013421 (2003).","journal-title":"Neuron"},{"key":"64443_CR7","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","volume":"23","author":"MA Busche","year":"2020","unstructured":"Busche, M. A. & Hyman, B. T. Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease. Nat. Neurosci. 23, 1183\u20131193 (2020).","journal-title":"Nat. Neurosci."},{"key":"64443_CR8","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe, D. J. Alzheimer\u2019s disease: genes, proteins, and therapy. Physiol. Rev. 81, 742\u2013760 (2001).","journal-title":"Physiol. Rev."},{"key":"64443_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43822-x","volume":"15","author":"B Frieg","year":"2024","unstructured":"Frieg, B. et al. Cryo-EM structures of lipidic fibrils of amyloid-\u03b2 (1\u201340). Nat. Commun. 15, 1297 (2024).","journal-title":"Nat. Commun."},{"key":"64443_CR10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2023089118","volume":"118","author":"U Ghosh","year":"2021","unstructured":"Ghosh, U., Thurber, K. R., Yau, W.-M. & Tycko, R. Molecular structure of a prevalent amyloid-\u03b2 fibril polymorph from Alzheimer\u2019s disease brain tissue. Proc. Natl Acad. Sci. USA 118, e2023089118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"64443_CR11","doi-asserted-by":"publisher","first-page":"108092","DOI":"10.1016\/j.jsb.2024.108092","volume":"216","author":"Z Fu","year":"2024","unstructured":"Fu, Z. et al. An electrostatic cluster guides A\u03b240 fibril formation in sporadic and Dutch-type cerebral amyloid angiopathy. J. Struct. Biol. 216, 108092 (2024).","journal-title":"J. Struct. Biol."},{"key":"64443_CR12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","volume":"125","author":"J Wagner","year":"2013","unstructured":"Wagner, J. et al. Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson\u2019s disease. Acta Neuropathol. 125, 795\u2013813 (2013).","journal-title":"Acta Neuropathol."},{"key":"64443_CR13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00401-015-1483-3","volume":"130","author":"J Wagner","year":"2015","unstructured":"Wagner, J. et al. Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies. Acta Neuropathol. 130, 619\u2013631 (2015).","journal-title":"Acta Neuropathol."},{"key":"64443_CR14","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00401-014-1265-3","volume":"127","author":"J Levin","year":"2014","unstructured":"Levin, J. et al. The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started post-disease onset. Acta Neuropathol. 127, 779\u2013780 (2014).","journal-title":"Acta Neuropathol."},{"key":"64443_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/mds.27562","volume":"34","author":"A Heras-Garvin","year":"2019","unstructured":"Heras-Garvin, A. et al. Anle138b modulates \u03b1-synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy. Mov. Disord. 34, 255\u2013263 (2019).","journal-title":"Mov. Disord."},{"key":"64443_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00401-019-02023-x","volume":"138","author":"M Wegrzynowicz","year":"2019","unstructured":"Wegrzynowicz, M. et al. Depopulation of dense \u03b1-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson\u2019s disease model. Acta Neuropathol. 138, 575\u2013595 (2019).","journal-title":"Acta Neuropathol."},{"key":"64443_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.15252\/emmm.201707825","volume":"10","author":"A Martinez Hernandez","year":"2018","unstructured":"Martinez Hernandez, A. et al. The diphenylpyrazole compound anle138b blocks A\u03b2 channels and rescues disease phenotypes in a mouse model for amyloid pathology. EMBO Mol. Med. 10, 32\u201347 (2018).","journal-title":"EMBO Mol. Med."},{"key":"64443_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-019-0522-z","volume":"11","author":"M Brendel","year":"2019","unstructured":"Brendel, M. et al. Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer\u2019s disease tau. Alzheimers Res. Ther. 11, 1\u201311 (2019).","journal-title":"Alzheimers Res. Ther."},{"key":"64443_CR19","doi-asserted-by":"publisher","first-page":"104078","DOI":"10.1016\/j.ebiom.2022.104021","volume":"80","author":"J Levin","year":"2022","unstructured":"Levin, J. et al. Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: a randomised, double-blind, placebo-controlled phase 1a trial. EBioMedicine 80, 104078 (2022).","journal-title":"EBioMedicine"},{"key":"64443_CR20","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1111\/j.1742-4658.2009.07307.x","volume":"276","author":"SA Hudson","year":"2009","unstructured":"Hudson, S. A., Ecroyd, H., Kee, T. W. & Carver, J. A. The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds. FEBS J. 276, 5960\u20135972 (2009).","journal-title":"FEBS J."},{"key":"64443_CR21","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1016\/j.bmc.2011.08.052","volume":"19","author":"Y Masuda","year":"2011","unstructured":"Masuda, Y. et al. Solid-state NMR analysis of interaction sites of curcumin and 42-residue amyloid \u03b2-protein fibrils. Bioorg. Med. Chem. 19, 5967\u20135974 (2011).","journal-title":"Bioorg. Med. Chem."},{"key":"64443_CR22","doi-asserted-by":"publisher","first-page":"9704","DOI":"10.1021\/ja026691b","volume":"124","author":"A Lange","year":"2002","unstructured":"Lange, A., Luca, S. & Baldus, M. Structural constraints from proton-mediated rare-spin correlation spectroscopy in rotating solids. J. Am. Chem. Soc. 124, 9704\u20139705 (2002).","journal-title":"J. Am. Chem. Soc."},{"key":"64443_CR23","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1021\/bi101307h","volume":"50","author":"Y He","year":"2011","unstructured":"He, Y. et al. A nuclear magnetic resonance-based structural rationale for contrasting stoichiometry and ligand binding site(s) in fatty acid-binding proteins. Biochemistry 50, 1283\u20131295 (2011).","journal-title":"Biochemistry"},{"key":"64443_CR24","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.jmb.2008.11.022","volume":"385","author":"SD Cady","year":"2009","unstructured":"Cady, S. D., Mishanina, T. V. & Hong, M. Structure of amantadine-bound M2 transmembrane peptide of influenza A in lipid bilayers from magic-angle-spinning solid-state NMR: the role of Ser31 in amantadine binding. J. Mol. Biol. 385, 1127\u20131141 (2009).","journal-title":"J. Mol. Biol."},{"key":"64443_CR25","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.1021\/ja960253l","volume":"118","author":"JC Facelli","year":"1996","unstructured":"Facelli, J. C., Pugmire, R. J. & Grant, D. M. Effects of hydrogen bonding in the calculation of 15N chemical shift tensors: benzamide. J. Am. Chem. Soc. 118, 5488\u20135489 (1996).","journal-title":"J. Am. Chem. Soc."},{"key":"64443_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ssnmr.2018.03.002","volume":"92","author":"S Paramasivam","year":"2018","unstructured":"Paramasivam, S., Gronenborn, A. M. & Polenova, T. Backbone amide 15N chemical shift tensors report on hydrogen bonding interactions in proteins: a magic angle spinning NMR study. Solid State Nucl. Magn. Reson. 92, 1\u20136 (2018).","journal-title":"Solid State Nucl. Magn. Reson."},{"key":"64443_CR27","doi-asserted-by":"publisher","first-page":"10958","DOI":"10.1021\/ja101537p","volume":"132","author":"LB Andreas","year":"2010","unstructured":"Andreas, L. B. et al. Magic angle spinning NMR investigation of influenza A M218-60: support for an allosteric mechanism of inhibition. J. Am. Chem. Soc. 132, 10958\u201310960 (2010).","journal-title":"J. Am. Chem. Soc."},{"key":"64443_CR28","doi-asserted-by":"publisher","first-page":"6813","DOI":"10.1021\/acs.jpcb.7b04198","volume":"121","author":"F-Y Lin","year":"2017","unstructured":"Lin, F.-Y. & MacKerell, A. D. Jr Do halogen\u2013hydrogen bond donor interactions dominate the favorable contribution of halogens to ligand\u2013protein binding?. J. Phys. Chem. B 121, 6813\u20136821 (2017).","journal-title":"J. Phys. Chem. B"},{"key":"64443_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32797-w","volume":"13","author":"L Antonschmidt","year":"2022","unstructured":"Antonschmidt, L. et al. The clinical drug candidate anle138b binds in a cavity of lipidic \u03b1-synuclein fibrils. Nat. Commun. 13, 5385 (2022).","journal-title":"Nat. Commun."},{"key":"64443_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ymeth.2023.04.002","volume":"214","author":"R Dervi\u015fo\u011flu","year":"2023","unstructured":"Dervi\u015fo\u011flu, R. et al. Anle138b interaction in \u03b1-synuclein aggregates by dynamic nuclear polarization NMR. Methods 214, 18\u201327 (2023).","journal-title":"Methods"},{"key":"64443_CR31","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1016\/j.cell.2021.08.013","volume":"184","author":"MR Sawaya","year":"2021","unstructured":"Sawaya, M. R. et al. The expanding amyloid family: structure, stability, function, and pathogenesis. Cell 184, 4857\u20134873 (2021).","journal-title":"Cell"},{"key":"64443_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54091-7","volume":"15","author":"S Karimi-Farsijani","year":"2024","unstructured":"Karimi-Farsijani, S. et al. Cryo-EM structure of a lysozyme-derived amyloid fibril from hereditary amyloidosis. Nat. Commun. 15, 9648 (2024).","journal-title":"Nat. Commun."},{"key":"64443_CR33","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41586-019-1026-5","volume":"568","author":"B Falcon","year":"2019","unstructured":"Falcon, B. et al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature 568, 420\u2013423 (2019).","journal-title":"Nature"},{"key":"64443_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34552-7","volume":"13","author":"B Frieg","year":"2022","unstructured":"Frieg, B. et al. The 3D structure of lipidic fibrils of \u03b1-synuclein. Nat. Commun. 13, 6810 (2022).","journal-title":"Nat. Commun."},{"key":"64443_CR35","doi-asserted-by":"publisher","first-page":"7589","DOI":"10.1039\/D0CC01161D","volume":"56","author":"B Frieg","year":"2020","unstructured":"Frieg, B., Gremer, L., Heise, H., Willbold, D. & Gohlke, H. Binding modes of thioflavin T and Congo red to the fibril structure of amyloid-\u03b2 (1\u201342). Chem. Commun. 56, 7589\u20137592 (2020).","journal-title":"Chem. Commun."},{"key":"64443_CR36","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41589-023-01370-x","volume":"19","author":"Y Tao","year":"2023","unstructured":"Tao, Y. et al. Structural mechanism for specific binding of chemical compounds to amyloid fibrils. Nat. Chem. Biol. 19, 1235\u20131245 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"64443_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38537-y","volume":"14","author":"GE Merz","year":"2023","unstructured":"Merz, G. E. et al. Stacked binding of a PET ligand to Alzheimer\u2019s tau paired helical filaments. Nat. Commun. 14, 3048 (2023).","journal-title":"Nat. Commun."},{"key":"64443_CR38","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1016\/j.cell.2023.06.004","volume":"186","author":"J Xiang","year":"2023","unstructured":"Xiang, J. et al. Development of an \u03b1-synuclein positron emission tomography tracer for imaging synucleinopathies. Cell 186, 3350\u20133367.e3319 (2023).","journal-title":"Cell"},{"key":"64443_CR39","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00401-021-02294-3","volume":"141","author":"Y Shi","year":"2021","unstructured":"Shi, Y. et al. Cryo-EM structures of tau filaments from Alzheimer\u2019s disease with PET ligand APN-1607. Acta Neuropathol. 141, 697\u2013708 (2021).","journal-title":"Acta Neuropathol."},{"key":"64443_CR40","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1021\/jacs.1c12056","volume":"144","author":"P Duan","year":"2022","unstructured":"Duan, P. et al. Binding sites of a positron emission tomography imaging agent in Alzheimer\u2019s \u03b2-amyloid fibrils studied using 19F solid-state NMR. J. Am. Chem. Soc. 144, 1416\u20131430 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"64443_CR41","doi-asserted-by":"publisher","first-page":"12489","DOI":"10.1021\/ja507382j","volume":"136","author":"B-M Emeline","year":"2014","unstructured":"Emeline, B.-M. et al. Rapid proton-detected NMR assignment for proteins with fast magic angle spinning. J. Am. Chem. Soc. 136, 12489\u201312497 (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"64443_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-54919-z","volume":"9","author":"MS Saravanan","year":"2019","unstructured":"Saravanan, M. S. et al. The small molecule inhibitor anle145c thermodynamically traps human islet amyloid peptide in the form of non-cytotoxic oligomers. Sci. Rep. 9, 19023 (2019).","journal-title":"Sci. Rep."},{"key":"64443_CR43","doi-asserted-by":"publisher","first-page":"11337","DOI":"10.1021\/acs.langmuir.3c01023","volume":"39","author":"V Forooqi Motlaq","year":"2023","unstructured":"Forooqi Motlaq, V. et al. Spontaneous formation of ultrasmall unilamellar vesicles in mixtures of an amphiphilic drug and a phospholipid. Langmuir 39, 11337\u201311344 (2023).","journal-title":"Langmuir"},{"key":"64443_CR44","doi-asserted-by":"crossref","unstructured":"Najbauer, E. E. et al. Probing membrane protein insertion into lipid bilayers by solid-state NMR. Chem. Phys. Chem. 20, 302\u2013310 (2018).","DOI":"10.1002\/cphc.201800793"},{"key":"64443_CR45","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/prot.20449","volume":"59","author":"WF Vranken","year":"2005","unstructured":"Vranken, W. F. et al. The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins 59, 687\u2013696 (2005).","journal-title":"Proteins"},{"key":"64443_CR46","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1021\/ja311571v","volume":"135","author":"Y Liu","year":"2013","unstructured":"Liu, Y., Villamena, F. A., Rockenbauer, A., Song, Y. & Zweier, J. L. Structural factors controlling the spin\u2013spin exchange coupling: EPR spectroscopic studies of highly asymmetric trityl\u2013nitroxide biradicals. J. Am. Chem. Soc. 135, 2350\u20132356 (2013).","journal-title":"J. Am. Chem. Soc."},{"key":"64443_CR47","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2013a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"64443_CR48","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1073\/pnas.0608582104","volume":"104","author":"T Cedervall","year":"2007","unstructured":"Cedervall, T. et al. Understanding the nanoparticle\u2013protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc. Natl Acad. Sci. USA 104, 2050\u20132055 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"64443_CR49","doi-asserted-by":"publisher","first-page":"19265","DOI":"10.1039\/C9NR05790K","volume":"11","author":"D Prozeller","year":"2019","unstructured":"Prozeller, D., Morsbach, S. & Landfester, K. Isothermal titration calorimetry as a complementary method for investigating nanoparticle\u2013protein interactions. Nanoscale 11, 19265\u201319273 (2019).","journal-title":"Nanoscale"},{"key":"64443_CR50","doi-asserted-by":"publisher","first-page":"8036863","DOI":"10.1155\/2019\/8036863","volume":"2019","author":"L Yuan","year":"2019","unstructured":"Yuan, L. et al. Interaction of mitoxantrone-loaded cholesterol modified pullulan nanoparticles with human serum albumin and effect on drug release. J. Nanomater. 2019, 8036863 (2019).","journal-title":"J. Nanomater."},{"key":"64443_CR51","doi-asserted-by":"publisher","first-page":"121675","DOI":"10.1016\/j.molliq.2023.121675","volume":"379","author":"AK Prajapati","year":"2023","unstructured":"Prajapati, A. K. & Choudhary, S. Physicochemical insights into the micellar delivery of doxycycline and minocycline to the carrier protein in aqueous environment. J. Mol. Liq. 379, 121675 (2023).","journal-title":"J. Mol. Liq."},{"key":"64443_CR52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"64443_CR53","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/s41592-019-0580-y","volume":"16","author":"D Tegunov","year":"2019","unstructured":"Tegunov, D. & Cramer, P. Real-time cryo-electron microscopy data preprocessing with Warp. Nat. Methods 16, 1146\u20131152 (2019).","journal-title":"Nat. Methods"},{"key":"64443_CR54","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1107\/S2052252520000081","volume":"7","author":"J Zivanov","year":"2020","unstructured":"Zivanov, J., Nakane, T. & Scheres, S. H. Estimation of high-order aberrations and anisotropic magnification from cryo-EM data sets in RELION-3.1. IUCrJ 7, 253\u2013267 (2020).","journal-title":"IUCrJ"},{"key":"64443_CR55","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jsb.2017.02.003","volume":"198","author":"S He","year":"2017","unstructured":"He, S. & Scheres, S. H. Helical reconstruction in RELION. J. Struct. Biol. 198, 163\u2013176 (2017).","journal-title":"J. Struct. Biol."},{"key":"64443_CR56","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou, A. & Grigorieff, N. CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216\u2013221 (2015).","journal-title":"J. Struct. Biol."},{"key":"64443_CR57","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s42003-019-0437-z","volume":"2","author":"T Wagner","year":"2019","unstructured":"Wagner, T. et al. SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM. Commun. Biol. 2, 218 (2019).","journal-title":"Commun. Biol."},{"key":"64443_CR58","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D. Struct. Biol. 75, 861\u2013877 (2019).","journal-title":"Acta Crystallogr. D. Struct. Biol."},{"key":"64443_CR59","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D. Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"64443_CR60","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D. Biol. Crystallogr. 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"64443_CR61","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","volume":"29","author":"S Pronk","year":"2013","unstructured":"Pronk, S. et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29, 845\u2013854 (2013).","journal-title":"Bioinformatics"},{"key":"64443_CR62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1, 19\u201325 (2015).","journal-title":"SoftwareX"},{"key":"64443_CR63","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: an N\u00b7log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089\u201310092 (1993).","journal-title":"J. Chem. Phys."},{"key":"64443_CR64","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann, U. et al. A smooth particle mesh Ewald method. J. Chem. Phys. 103, 8577\u20138593 (1995).","journal-title":"J. Chem. Phys."},{"key":"64443_CR65","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1021\/ct700200b","volume":"4","author":"B Hess","year":"2008","unstructured":"Hess, B. P-LINCS: A parallel linear constraint solver for molecular simulation. J. Chem. Theory Comput. 4, 116\u2013122 (2008).","journal-title":"J. Chem. Theory Comput."},{"key":"64443_CR66","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/jcc.540130805","volume":"13","author":"S Miyamoto","year":"1992","unstructured":"Miyamoto, S. & Kollman, P. A. Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models. J. Comput. Chem. 13, 952\u2013962 (1992).","journal-title":"J. Comput. Chem."},{"key":"64443_CR67","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1103\/PhysRev.159.98","volume":"159","author":"L Verlet","year":"1967","unstructured":"Verlet, L. Computer \u2018experiments\u2019 on classical fluids. I. Thermodynamical properties of Lennard-Jones molecules. Phys. Rev. 159, 98\u2013103 (1967).","journal-title":"Phys. Rev."},{"key":"64443_CR68","doi-asserted-by":"publisher","first-page":"014101","DOI":"10.1063\/1.2408420","volume":"126","author":"G Bussi","year":"2007","unstructured":"Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. J. Chem. Phys. 126, 014101 (2007).","journal-title":"J. Chem. Phys."},{"key":"64443_CR69","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1063\/1.328693","volume":"52","author":"M Parrinello","year":"1981","unstructured":"Parrinello, M. & Rahman, A. Polymorphic transitions in single crystals: a new molecular dynamics method. J. Appl. Phys. 52, 7182\u20137190 (1981).","journal-title":"J. Appl. Phys."},{"key":"64443_CR70","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1021\/ct300400x","volume":"8","author":"RB Best","year":"2012","unstructured":"Best, R. B. et al. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone \u03d5, \u03c8 and side-chain \u03c71 and \u03c72 dihedral angles. J. Chem. Theory Comput. 8, 3257\u20133273 (2012).","journal-title":"J. Chem. Theory Comput."},{"key":"64443_CR71","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71\u201373 (2017).","journal-title":"Nat. Methods"},{"key":"64443_CR72","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1021\/jp973084f","volume":"102","author":"AD MacKerell Jr","year":"1998","unstructured":"MacKerell, A. D. Jr et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B 102, 3586\u20133616 (1998).","journal-title":"J. Phys. Chem. B"},{"key":"64443_CR73","doi-asserted-by":"publisher","first-page":"7830","DOI":"10.1021\/jp101759q","volume":"114","author":"JB Klauda","year":"2010","unstructured":"Klauda, J. B. et al. Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types. J. Phys. Chem. B 114, 7830\u20137843 (2010).","journal-title":"J. Phys. Chem. B"},{"key":"64443_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-3-1","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle, N. M. et al. Open Babel: An open chemical toolbox. J. Cheminform. 3, 1\u201314 (2011).","journal-title":"J. Cheminform."},{"key":"64443_CR75","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jcc.21367","volume":"31","author":"K Vanommeslaeghe","year":"2010","unstructured":"Vanommeslaeghe, K. et al. CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 31, 671\u2013690 (2010).","journal-title":"J. Comput. Chem."},{"key":"64443_CR76","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1021\/ci300363c","volume":"52","author":"K Vanommeslaeghe","year":"2012","unstructured":"Vanommeslaeghe, K. & MacKerell, A. D. Jr Automation of the CHARMM General Force Field (CGenFF) I: bond perception and atom typing. J. Chem. Inf. Model. 52, 3144\u20133154 (2012).","journal-title":"J. Chem. Inf. Model."},{"key":"64443_CR77","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1021\/ci3003649","volume":"52","author":"K Vanommeslaeghe","year":"2012","unstructured":"Vanommeslaeghe, K., Raman, E. P. & MacKerell, A. D. Jr Automation of the CHARMM General Force Field (CGenFF) II: assignment of bonded parameters and partial atomic charges. J. Chem. Inf. Model. 52, 3155\u20133168 (2012).","journal-title":"J. Chem. Inf. Model."},{"key":"64443_CR78","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.1016\/j.bmc.2016.06.034","volume":"24","author":"IS Guti\u00e9rrez","year":"2016","unstructured":"Guti\u00e9rrez, I. S. et al. Parametrization of halogen bonds in the CHARMM general force field: improved treatment of ligand\u2013protein interactions. Bioorg. Med. Chem. 24, 4812\u20134825 (2016).","journal-title":"Bioorg. Med. Chem."},{"key":"64443_CR79","unstructured":"Schr\u00f6dinger, L. L. C. The PyMOL Molecular Graphics System, Version 2.5. (2020)."},{"key":"64443_CR80","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1016\/j.cpc.2013.07.018","volume":"184","author":"C Blau","year":"2013","unstructured":"Blau, C. & Grubmuller, H. g_contacts: fast contact search in bio-molecular ensemble data. Comput. Phys. Commun. 184, 2856\u20132859 (2013).","journal-title":"Comput. Phys. Commun."},{"key":"64443_CR81","doi-asserted-by":"publisher","first-page":"142a","DOI":"10.1016\/j.bpj.2018.11.790","volume":"116","author":"R Briones","year":"2019","unstructured":"Briones, R. et al. Gromaps: a GROMACS-based toolset to analyse density maps derived from molecular dynamics simulations. Biophys. J. 116, 142a\u2013143a (2019).","journal-title":"Biophys. J."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64443-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64443-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64443-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:02:36Z","timestamp":1759507356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64443-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64443"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64443-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6770178\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"28 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A. G. and C. G. are co-founders of MODAG. A.G. is a full-time employee of MODAG. A. L. and S.R. are partly employed by MODAG and are beneficiaries of the phantom share program of MODAG GmbH. A.L., S.R., C.G., and A.G. are co-inventors of WO\/2010\/000372. Anle138b is licensed by Teva Pharmaceutical Industries Ltd and is in clinical development in collaboration with MODAG. B.F. is an AstraZeneca employee. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8850"}}